公司概覽
業務類別 --
業務概覽 CStone Pharmaceuticals is engaged in developing and commercializing of immuno-oncology and molecularly targeted drugs to address unmet medical needs in cancer treatment.
公司地址 218 Xinghu Street, C1 Building, North Block, Suzhou Industrial Park, Suzhou, CHN, 215123
電話號碼 +86 51287186550
傳真號碼 --
公司網頁 https://www.cstonepharma.com
員工數量 136
 
公司高管 / 董事會成員
公司高管
高管 職務 年薪 更新日期
Dr. Jianxin Yang, M.D.,PhD Director, Chief Executive Officer and President, Research and Development -- 27/04/2026
 
董事會成員
董事會 職務 更新日期
Mr. Kenneth Howard Jarrett Independent Director 27/04/2026
Ms. Catherine Yen Independent Director 27/04/2026
Dr. Jianxin Yang, M.D.,PhD Director, Chief Executive Officer and President, Research and Development 27/04/2026
Ms. Xie Fang Independent Director 27/04/2026
Mr. Kenneth Walton Hitchner, III Director 27/04/2026
Dr. Wei Li, PhD Non-Executive Chairman of the Board 27/04/2026
Mr. Edward Hu Director 27/04/2026
 
所屬ETF (更新日期: 23/05/2026 04:59)
代號 名稱 佔比% 持有日期
IEMGiShares Core MSCI Emerging Markets ETF0.90%30/04/2026
PIEInvesco DW Emerging Markets Momt ETF0.16%30/04/2026
SPEMState Street® SPDR® Portfolio EM ETF0.09%30/04/2026
VTVanguard Total World Stock ETF0.05%30/04/2026
EWXState Street® SPDR® S&P® EM Sm Cp ETF0.04%30/04/2026
ECNSiShares MSCI China Small-Cap ETF0.03%30/04/2026
EEMSiShares MSCI Emerging Markets Sm-Cp ETF0.02%30/04/2026
GXCState Street® SPDR® S&P® China ETF0.01%30/04/2026
GMFState Street® SPDR® S&P® Em AsiaPac ETF0.002%30/04/2026
TLTEFlexShares Mstar EmgMkts FctTilt ETF0.001%30/04/2026
AOMiShares Core 40/60 Moderate Allc ETF<0.000001%06/03/2026
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.